Characterization of differential antibody production against hepatitis C virus in different HCV infection status

BACKGROUND: The Centers for Disease Control and Prevention (CDC) issued an update on hepatitis C virus (HCV) testing approach, in which it omitted the use of recombinant immunoblot assay (RIBA) in the diagnostic algorithm and recommended that future studies are needed to evaluate the performance of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafik, Mona, Bakr, Salwa, Soliman, Dina, Mohammed, Nesrine, Ragab, Dina, ElHady, Walid Abd, Samir, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928299/
https://www.ncbi.nlm.nih.gov/pubmed/27357382
http://dx.doi.org/10.1186/s12985-016-0572-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928299/
https://www.ncbi.nlm.nih.gov/pubmed/27357382
http://dx.doi.org/10.1186/s12985-016-0572-9

Ejemplares similares